AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza…
Drug Manufacturers - General
GB, Cambridge [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 82.40 | 80.80 | 82.06 | 80.72 | 79.54 | 77.61 | 81.20 | 82.06 | 80.78 | 77.66 | 79.82 | 80.09 | 66.76 | 72.06 | 81.95 | |
| Profit Margin | 22.93 | 24.21 | 29.72 | 22.51 | 9.94 | 4.73 | 11.43 | 15.21 | 13.36 | 9.76 | 5.47 | 12.01 | 0.30 | 7.41 | 13.00 | |
| Operating Margin | 35.19 | 34.55 | 38.09 | 29.13 | 14.44 | 8.19 | 16.65 | 21.31 | 16.37 | 15.33 | 11.99 | 19.39 | 2.82 | 8.47 | 17.88 | |
|
EPS Growth
|
23.57 | 7.90 | 30.89 | -31.92 | -59.12 | -51.96 | 127.55 | 24.22 | -14.44 | -28.27 | -39.41 | 136.89 | -96.72 | 2,550.00 | 81.13 | |
| EPS USD | 519.00 | 560.00 | 733.00 | 499.00 | 204.00 | 98.00 | 223.00 | 277.00 | 237.00 | 170.00 | 103.00 | 244.00 | 8.00 | 212.00 | 384.00 | |
| Return on Assets (ROA) | 13.69 | 14.35 | 18.90 | 11.76 | 4.57 | 2.10 | 4.70 | 5.60 | 4.74 | 3.55 | 2.18 | 4.79 | 0.11 | 3.41 | 5.89 | |
| Return on Equity (ROE) | 36.40 | 34.69 | 42.95 | 26.53 | 11.01 | 6.28 | 15.28 | 23.56 | 20.06 | 17.28 | 10.17 | 20.46 | 0.29 | 8.88 | 15.21 | |
| Return on Invested Capital (ROIC) | 25.21 | 25.79 | 31.81 | 19.62 | 8.69 | 6.95 | 11.29 | 14.85 | 14.45 | 11.03 | 7.39 | 11.51 | -0.65 | 7.46 | 10.45 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 20.59 | 17.10 | 17.66 | 19.26 | 18.56 | 18.51 | 25.04 | 26.88 | 28.11 | 31.51 | 29.70 | 30.54 | 29.21 | 30.30 | 28.31 | |
| Debt/Equity | 54.73 | 41.34 | 40.13 | 43.43 | 44.68 | 55.25 | 81.41 | 113.16 | 119.03 | 153.30 | 138.85 | 130.46 | 78.39 | 78.93 | 73.12 | |
| Debt/EBITDA | 9.86 | -9.99 | 12.19 | 23.31 | 13.89 | 81.64 | 125.97 | 161.66 | 213.90 | 199.33 | 183.27 | 149.90 | 323.23 | 247.30 | 163.77 | |
|
Debt/Capitalization
|
35.37 | 29.25 | 28.64 | 30.28 | 30.88 | 35.59 | 44.88 | 53.09 | 54.34 | 60.52 | 58.13 | 56.61 | 43.94 | 44.11 | 42.24 | |
| Long-Term Debt/Capitalization | 31.23 | 28.98 | 23.99 | 28.39 | 27.00 | 29.96 | 43.33 | 49.40 | 50.98 | 58.20 | 55.27 | 53.53 | 42.39 | 39.01 | 37.24 | |
| Interest Debt per Share USD | 8.64 | 7.39 | 7.57 | 8.94 | 8.68 | 9.35 | 12.76 | 14.38 | 15.26 | 16.21 | 15.11 | 16.53 | 22.62 | 19.75 | 19.50 | |
| Debt Growth | -4.57 | -15.14 | -2.78 | 10.53 | 0.64 | 4.50 | 38.83 | 11.66 | 5.94 | 7.33 | -4.64 | 11.81 | 51.04 | -5.03 | -2.09 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 134.69 | 149.71 | 149.23 | 137.01 | 126.69 | 96.35 | 107.65 | 86.93 | 80.27 | 95.70 | 85.90 | 96.24 | 116.15 | 85.93 | 82.03 | |
| Quick Ratio | 124.77 | 139.69 | 137.47 | 122.18 | 114.80 | 85.04 | 93.24 | 71.63 | 61.74 | 77.96 | 68.28 | 76.43 | 76.40 | 68.06 | 64.27 | |
| Cash Ratio | 56.22 | 65.93 | 48.06 | 55.39 | 57.42 | 36.70 | 41.97 | 32.89 | 20.29 | 29.65 | 29.64 | 38.57 | 28.01 | 23.45 | 19.12 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 330.00 | 379.85 | 325.38 | 261.67 | 275.59 | 298.06 | 216.80 | 176.78 | 142.27 | 170.80 | 154.12 | 131.69 | 138.45 | 263.69 | 152.43 | |
| Receivables Turnover | - - | 305.50 | - - | - - | -21,605.88 | -22,890.35 | -22,461.82 | -25,276.92 | -24,155.91 | -17,531.75 | 680.17 | 699.34 | 347.81 | 614.96 | 544.92 | |
| Payables Turnover | 66.48 | 73.77 | 67.14 | 58.49 | 50.77 | 49.15 | 39.84 | 39.35 | 37.09 | 38.44 | 35.18 | 33.57 | 65.67 | 65.08 | 253.08 | |
|
Asset Turnover
|
59.73 | 59.27 | 63.58 | 52.25 | 46.00 | 44.53 | 41.10 | 36.79 | 35.46 | 36.42 | 39.73 | 39.89 | 35.51 | 45.97 | 45.30 | |
| Fixed Turnover | 448.94 | 478.21 | 522.82 | 459.40 | 441.92 | 434.19 | 385.28 | 335.89 | 295.01 | 297.67 | 292.55 | 298.50 | 367.88 | 469.37 | 436.21 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 963.52 | 1,112.68 | 1,305.61 | 850.52 | 749.90 | 221.91 | 382.70 | 354.19 | 243.83 | 238.69 | 204.19 | 395.25 | 81.23 | 279.12 | 515.61 | |
| Asset Coverage | 200 | 200 | 300 | 200 | 200 | 200 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | 103.82 | 111.31 | 83.84 | 67.39 | 71.32 | 65.09 | 22.08 | 24.66 | 20.09 | 13.70 | 16.29 | 23.55 | 19.37 | 33.55 | 36.14 | |
| EBITDA Coverage | 1,100 | 1,400 | 1,400 | 1,100 | 1,600 | 500 | 600 | 500 | 400 | 500 | 400 | 600 | 500 | 600 | 800 | |
| Dividend Coverage | -200 | -200 | -200 | -100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -100 | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | 4.37 | 5.13 | 5.98 | 6.14 | 4.67 | 3.93 | 4.05 | 5.14 | 4.02 | 3.68 | 2.74 | 2.72 | 2.32 | 2.08 | 2.14 | |
| Earnings Yield | 11.04 | 12.29 | 15.86 | 10.55 | 3.45 | 1.38 | 3.29 | 5.06 | 3.43 | 2.27 | 1.02 | 2.44 | 0.07 | 1.57 | 2.85 | |
|
Price/Earnings (P/E)
|
905.75 | 813.73 | 630.50 | 947.53 | 2,901.47 | 7,262.02 | 3,043.22 | 1,978.08 | 2,918.08 | 4,398.74 | 9,822.72 | 4,105.84 | 148,678.95 | 6,383.02 | 3,509.97 | |
| Price/Earnings Growth (PEG) | 38.43 | 103.01 | 20.41 | -29.68 | -49.08 | -139.76 | 23.86 | 81.69 | -202.08 | -155.60 | -249.23 | 29.99 | -1,537.19 | 2.50 | 43.26 | |
|
Price/Book (P/B)
|
329.73 | 282.30 | 270.77 | 251.36 | 319.33 | 456.21 | 464.96 | 465.96 | 585.37 | 760.29 | 998.96 | 839.99 | 424.06 | 566.66 | 533.99 | |
| Price/Tangible Book (P/TB) | 329.73 | 282.30 | 270.77 | 251.36 | 319.33 | 456.21 | 464.96 | 465.96 | 585.37 | 760.29 | 998.96 | 839.99 | 424.06 | 566.66 | 533.99 | |
| Price/Sales (P/S) | 207.66 | 196.97 | 187.38 | 213.30 | 288.44 | 343.13 | 347.95 | 300.90 | 389.81 | 429.12 | 537.78 | 493.00 | 445.04 | 473.21 | 456.26 | |
|
Price/Cash Flow (P/CF)
|
580.30 | 613.57 | 804.79 | 858.75 | 1,002.18 | 1,268.64 | 2,586.37 | 1,669.80 | 2,447.50 | 3,620.81 | 4,416.75 | 2,734.38 | 2,792.56 | 2,139.82 | 2,020.48 | |
| Price/Free CF (P/FCF) | 775.70 | 793.34 | 964.79 | 2,561.87 | 1,388.27 | 2,079.44 | 16,039.33 | 3,780.07 | 4,472.50 | 7,601.67 | 25,762.94 | 5,983.71 | 4,425.20 | 2,900.01 | 3,182.87 | |
| Price/Operating CF (P/OCF) | 580.30 | 613.57 | 804.79 | 858.75 | 1,002.18 | 1,268.64 | 2,586.37 | 1,669.80 | 2,447.50 | 3,620.81 | 4,416.75 | 2,734.38 | 2,792.56 | 2,139.82 | 2,020.48 |